The resolution designates September of each year as Duchenne Muscular Dystrophy (DMD) Awareness Month in New Jersey. DMD is a severe muscular degenerative disease caused by genetic mutations on the X chromosome, primarily affecting male infants at a rate of approximately 1 in 3,500. The disease leads to progressive muscle loss and function, often resulting in paralysis and serious cardiopulmonary complications. With symptoms typically appearing between the ages of two and three, individuals with DMD may require wheelchair assistance by their early teens and a breathing ventilator by age 20, with an average life expectancy of just 25 years. Although there is currently no cure, advancements in medical research and advocacy efforts are crucial for improving patient care and extending life expectancy.

The resolution emphasizes the importance of raising awareness about DMD to foster empathy, understanding, and community support for affected individuals and their families. It calls for the Governor to issue an annual proclamation recognizing September as DMD Awareness Month and encourages state agencies, organizations, and citizens to engage in awareness activities and programs throughout the month. By designating this month, New Jersey aims to support ongoing advocacy efforts, promote early diagnosis and treatment options, and ultimately improve the quality of life for those impacted by DMD.